Leisure Capital Management’s AstraZeneca AZN Stock Holding History

Leisure Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,148	Closed	-$291K	–	130
2018 Q2	$291K	Buy	4,148 +327	+9%	+$23.5K	0.25%	113
2018 Q1	$267K	Sell	3,821 -64	-2%	-$4.43K	0.23%	100
2017 Q4	$270K	Buy	3,885 +77	+2%	+$5.19K	0.22%	83
2017 Q3	$258K	Buy	+3,808	New	+$241K	0.23%	81

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Leisure Capital Management's AZN Position: Q3 2018 in Review

Leisure Capital Management sold out of AstraZeneca (AZN) in Q3 2018, closing a stake of 4,148 shares — an estimated $291K sold.

Leisure Capital Management first reported a position in AZN in Q3 2017 and held it in 4 quarters. The position peaked at $291K in Q2 2018. 544 funds tracked by Wall St. Rank hold AZN as of Q3 2018.

Leisure Capital Management reported no remaining AstraZeneca position as of Q3 2018 after selling out during the quarter.
Leisure Capital Management sold 4,148 AstraZeneca shares in Q3 2018, an estimated $291K.
Leisure Capital Management first reported a position in AstraZeneca in Q3 2017 and held it in 4 quarters.
Leisure Capital Management's AstraZeneca position peaked at $291K in Q2 2018.
544 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2018.

Based on Leisure Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.